7 octobre 2020
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.709.1865
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33026729
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8A1E7797710C8
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
P. Teiga et al., « Syndrome d’apnées obstructives du sommeil : CPAP ou orthèse d’avancement mandibulaire ? [Obstructive sleep apnea syndrome : CPAP or Mandibular Advancement Device?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.709.1865
Obstructive sleep apnea syndrome (OSAS) is a respiratory disorder affecting up to 49 % and 23 % of middle to older aged men and women respectively. CPAP (continuous positive airway pressure) is the gold-standard treatment for severe apneas. In mild and moderate forms of OSAS, mandibular advancement devices (MAD) are equally a first line of treatment. Both CPAP and MAD have their advantages and side effects. Patient tolerance to these two therapies varies according to different patient-parameters. In order to guide physicians and patients in choosing between these two treatments, we present a description of both treatment modalities.